Literature DB >> 20882440

Recent progress in dyskeratosis congenita.

Nobuhiro Nishio1, Seiji Kojima.   

Abstract

Dyskeratosis congenita (DC) is an inherited disease associated with nail dystrophy, abnormal skin pigmentation, oral leukoplakia, bone marrow failure and a predisposition to cancer. DC is a disease of defective telomere maintenance and patients with DC have very short telomeres. To date, mutations in six genes of telomerase and telomere components have been identified in patients with DC. Recently, mutations in telomerase and telomere components were also identified in patients with aplastic anemia, pulmonary fibrosis, and liver diseases who did not have mucocutaneous manifestations. These findings imply that defective telomere maintenance may cause not only classical DC but also a broad spectrum of diseases previously thought to be idiopathic, and have led to a new concept of diseases, termed "syndromes of telomere shortening". An understanding of the role of telomeres in these diseases is indispensable for diagnosis, genetic counseling and clinical management.

Entities:  

Mesh:

Year:  2010        PMID: 20882440     DOI: 10.1007/s12185-010-0695-5

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  50 in total

Review 1.  Dyskeratosis congenita in all its forms.

Authors:  I Dokal
Journal:  Br J Haematol       Date:  2000-09       Impact factor: 6.998

2.  Constitutive telomere length and gastric cancer risk: case-control analysis in Chinese Han population.

Authors:  Xiaonan Liu; Guoqiang Bao; Tingting Huo; Zizhong Wang; Xianli He; Guanglong Dong
Journal:  Cancer Sci       Date:  2009-04-30       Impact factor: 6.716

3.  TERC and TERT gene mutations in patients with bone marrow failure and the significance of telomere length measurements.

Authors:  Hong-Yan Du; Elena Pumbo; Jennifer Ivanovich; Ping An; Richard T Maziarz; Ulrike M Reiss; Deborah Chirnomas; Akiko Shimamura; Adrianna Vlachos; Jeffrey M Lipton; Rakesh K Goyal; Frederick Goldman; David B Wilson; Philip J Mason; Monica Bessler
Journal:  Blood       Date:  2008-10-17       Impact factor: 22.113

Review 4.  Dyskeratosis congenita: a disorder of defective telomere maintenance?

Authors:  Amanda J Walne; Anna Marrone; Inderjeet Dokal
Journal:  Int J Hematol       Date:  2005-10       Impact factor: 2.490

5.  Mutations of the human telomerase RNA gene (TERC) in aplastic anemia and myelodysplastic syndrome.

Authors:  Hiroki Yamaguchi; Gabriela M Baerlocher; Peter M Lansdorp; Stephen J Chanock; Olga Nunez; Elaine Sloand; Neal S Young
Journal:  Blood       Date:  2003-04-03       Impact factor: 22.113

6.  Unusual complications after bone marrow transplantation for dyskeratosis congenita.

Authors:  V Rocha; A Devergie; G Socié; P Ribaud; H Espérou; N Parquet; E Gluckman
Journal:  Br J Haematol       Date:  1998-10       Impact factor: 6.998

Review 7.  Cancer in dyskeratosis congenita.

Authors:  Blanche P Alter; Neelam Giri; Sharon A Savage; Philip S Rosenberg
Journal:  Blood       Date:  2009-03-12       Impact factor: 22.113

8.  Mutations in the telomerase component NHP2 cause the premature ageing syndrome dyskeratosis congenita.

Authors:  Tom Vulliamy; Richard Beswick; Michael Kirwan; Anna Marrone; Martin Digweed; Amanda Walne; Inderjeet Dokal
Journal:  Proc Natl Acad Sci U S A       Date:  2008-06-03       Impact factor: 11.205

9.  Telomerase reverse-transcriptase homozygous mutations in autosomal recessive dyskeratosis congenita and Hoyeraal-Hreidarsson syndrome.

Authors:  Anna Marrone; Amanda Walne; Hannah Tamary; Yuka Masunari; Michael Kirwan; Richard Beswick; Tom Vulliamy; Inderjeet Dokal
Journal:  Blood       Date:  2007-09-04       Impact factor: 22.113

10.  Exogenous TERC alone can enhance proliferative potential, telomerase activity and telomere length in lymphocytes from dyskeratosis congenita patients.

Authors:  Michael Kirwan; Richard Beswick; Tom Vulliamy; Amit C Nathwani; Amanda J Walne; Colin Casimir; Inderjeet Dokal
Journal:  Br J Haematol       Date:  2008-11-20       Impact factor: 6.998

View more
  11 in total

1.  Pneumococcal vaccine failure: can it be a primary immunodeficiency?

Authors:  Rita Moinho; Ana Brett; Gisela Ferreira; Sónia Lemos
Journal:  BMJ Case Rep       Date:  2014-06-12

2.  Peripheral blood lymphocyte telomere length as a predictor of response to immunosuppressive therapy in childhood aplastic anemia.

Authors:  Hirotoshi Sakaguchi; Nobuhiro Nishio; Asahito Hama; Nozomu Kawashima; Xinan Wang; Atsushi Narita; Sayoko Doisaki; Yinyan Xu; Hideki Muramatsu; Nao Yoshida; Yoshiyuki Takahashi; Kazuko Kudo; Hiroshi Moritake; Kazuhiro Nakamura; Ryoji Kobayashi; Etsuro Ito; Hiromasa Yabe; Shouichi Ohga; Akira Ohara; Seiji Kojima
Journal:  Haematologica       Date:  2014-05-09       Impact factor: 9.941

Review 3.  Potential relationship between inadequate response to DNA damage and development of myelodysplastic syndrome.

Authors:  Ting Zhou; Peishuai Chen; Jian Gu; Alexander J R Bishop; Linda M Scott; Paul Hasty; Vivienne I Rebel
Journal:  Int J Mol Sci       Date:  2015-01-05       Impact factor: 5.923

4.  Direct comparison of flow-FISH and qPCR as diagnostic tests for telomere length measurement in humans.

Authors:  Fernanda Gutierrez-Rodrigues; Bárbara A Santana-Lemos; Priscila S Scheucher; Raquel M Alves-Paiva; Rodrigo T Calado
Journal:  PLoS One       Date:  2014-11-19       Impact factor: 3.240

5.  DNA-dependent protein kinase in telomere maintenance and protection.

Authors:  Jiangdong Sui; Shichuan Zhang; Benjamin P C Chen
Journal:  Cell Mol Biol Lett       Date:  2020-01-17       Impact factor: 5.787

6.  Interstitial lung disease in a patient with dyskeratosis congenita.

Authors:  Hyun Jung Kim; Kyu Jin Kim; Kwan Ho Lee; Kyeong-Cheol Shin; Jin Hong Chung; Myung Soo Hyun; Ki-Hong Kim
Journal:  Tuberc Respir Dis (Seoul)       Date:  2013-02-28

Review 7.  Telomere structure and telomerase in health and disease (review).

Authors:  Daniel E Gomez; Romina G Armando; Hernán G Farina; Pablo Lorenzano Menna; Carolina S Cerrudo; P Daniel Ghiringhelli; Daniel F Alonso
Journal:  Int J Oncol       Date:  2012-08-29       Impact factor: 5.650

8.  Dyskeratosis congenita: a report of two cases.

Authors:  Anila Karunakaran; Rathy Ravindran; Mohammed Arshad; M Kodanda Ram; M K Shruthi Laxmi
Journal:  Case Rep Dent       Date:  2013-08-06

Review 9.  The diagnosis and treatment of dyskeratosis congenita: a review.

Authors:  M Soledad Fernández García; Julie Teruya-Feldstein
Journal:  J Blood Med       Date:  2014-08-21

10.  Spontaneous tumor development in bone marrow-rescued DNA-PKcs(3A/3A) mice due to dysfunction of telomere leading strand deprotection.

Authors:  S Zhang; S Matsunaga; Y-F Lin; B Sishc; Z Shang; J Sui; H-Y Shih; Y Zhao; O Foreman; M D Story; D J Chen; B P C Chen
Journal:  Oncogene       Date:  2015-11-30       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.